Literature DB >> 26680714

Synthesis, QSAR, and Molecular Dynamics Simulation of Amidino-substituted Benzimidazoles as Dipeptidyl Peptidase III Inhibitors.

Vesna Rastija, Dejan Agić, Sanja Tomiš, Sonja Nikolič, Marijana Hranjec, Karminski-Zamola Grace, Marija Abramić.   

Abstract

A molecular modeling study is performed on series of benzimidazol-based inhibitors of human dipeptidyl peptidase III (DPP III). An eight novel compounds were synthesized in excellent yields using green chemistry approach. This study is aimed to elucidate the structural features of benzimidazole derivatives required for antagonism of human DPP III activity using Quantitative Structure-Activity Relationship (QSAR) analysis, and to understand the mechanism of one of the most potent inhibitor binding into the active site of this enzyme, by molecular dynamics (MD) simulations. The best model obtained includes S3K and RDF045m descriptors which have explained 89.4 % of inhibitory activity. Depicted moiety for strong inhibition activity matches to the structure of most potent compound. MD simulation has revealed importance of imidazolinyl and phenyl groups in the mechanism of binding into the active site of human DPP III.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26680714     DOI: 10.17344/acsi.2015.1605

Source DB:  PubMed          Journal:  Acta Chim Slov        ISSN: 1318-0207            Impact factor:   1.735


  4 in total

Review 1.  Survey of Dipeptidyl Peptidase III Inhibitors: From Small Molecules of Microbial or Synthetic Origin to Aprotinin.

Authors:  Marija Abramić; Dejan Agić
Journal:  Molecules       Date:  2022-05-07       Impact factor: 4.927

2.  Coumarin Derivatives Act as Novel Inhibitors of Human Dipeptidyl Peptidase III: Combined In Vitro and In Silico Study.

Authors:  Dejan Agić; Maja Karnaš; Domagoj Šubarić; Melita Lončarić; Sanja Tomić; Zrinka Karačić; Drago Bešlo; Vesna Rastija; Maja Molnar; Boris M Popović; Miroslav Lisjak
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-05

3.  The Cholesterol-Lowering Effect of Alisol Acetates Based on HMG-CoA Reductase and Its Molecular Mechanism.

Authors:  Fei Xu; Hui Yu; Cai Lu; Jun Chen; Wei Gu
Journal:  Evid Based Complement Alternat Med       Date:  2016-10-30       Impact factor: 2.629

4.  Identfication of Potent LXRβ-Selective Agonists without LXRα Activation by In Silico Approaches.

Authors:  Meimei Chen; Fafu Yang; Jie Kang; Huijuan Gan; Xuemei Yang; Xinmei Lai; Yuxing Gao
Journal:  Molecules       Date:  2018-06-04       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.